Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 36Observational 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 13Rectal Neoplasms 10Colorectal Neoplasms 10Stomach Neoplasms 3Biliary Tract Neoplasms 2Triple Negative Breast Neoplasms 1Solid Tumor 1Recurrence 1Neoplastic Cells, Circulating 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Microbiota 1Gallbladder Neoplasms 1Fruquintinib 1Elderly Metastatic Colorectal Cancer Patients 1Colorectal Cancer Metastatic 1Colonic Neoplasms 1Cholangiocarcinoma 1Breast Cancer Organoids 1Breast Cancer Metastatic 1Brain Neoplasms 1Ampullary Adenocarcinoma 1

Interventions

Radiotherapy, Intensity-Modulated 5Docetaxel 4Cisplatin 4Radiation 2Positron Emission Tomography Computed Tomography 2Immunotherapy 2Fluorouracil 2Drug Therapy 2sintilimab 1neodymium pyrocatechin disulfonate 1X-Rays 1Restraint, Physical 1Quality of Life 1Patient Reported Outcome Measures 1Parenteral Nutrition 1Molecular Diagnostic Techniques 1Liquid Biopsy 1Induction Chemotherapy 1Immune Checkpoint Inhibitors 1Gemcitabine 1G(M1) Ganglioside 1Enteral Nutrition 1Endoscopy 1DMAC2L protein, human 1Chemoradiotherapy 1Capecitabine 1Blood Specimen Collection 1Biopsy 1Biological Therapy 1Biological Products 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Nasopharyngeal Carcinoma × Capecitabine × Clear all
NCT07618078 2026-06-03

Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPC

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Recruiting
900 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡